Patent · US Active

Thienopyrimidinedione derivatives as TRPA1 modulators

US9474758B2 · kind B2 · utility

0Cited by
10References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2015
Grant dateOct 25, 2016
Priority date
Expiry dateFeb 12, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is related to novel thienopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.